BCAL Diagnostics Limited BDX.AX Stock
BCAL Diagnostics Limited Price Chart
BCAL Diagnostics Limited BDX.AX Financial and Trading Overview
| BCAL Diagnostics Limited stock price | 0.11 AUD |
| Previous Close | 0.09 AUD |
| Open | 0.09 AUD |
| Bid | 0.09 AUD x N/A |
| Ask | 0.1 AUD x N/A |
| Day's Range | 0.09 - 0.09 AUD |
| 52 Week Range | 0.05 - 0.1 AUD |
| Volume | 50K AUD |
| Avg. Volume | 84.68K AUD |
| Market Cap | 19.45M AUD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BDX.AX Valuation Measures
| Enterprise Value | 12.85M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.770879 |
| Price/Book (mrq) | 2.5555556 |
| Enterprise Value/Revenue | 9.758 |
| Enterprise Value/EBITDA | N/A |
Trading Information
BCAL Diagnostics Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 34.32% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 AUD |
| 52 Week Low | 0.05 AUD |
| 50-Day Moving Average | 0.09 AUD |
| 200-Day Moving Average | 0.07 AUD |
BDX.AX Share Statistics
| Avg. Volume (3 month) | 84.68K AUD |
| Avg. Daily Volume (10-Days) | 93.38K AUD |
| Shares Outstanding | 211.44M |
| Float | 89.7M |
| Short Ratio | N/A |
| % Held by Insiders | 57.98% |
| % Held by Institutions | 9.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -332.51% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.45% |
| Return on Equity (ttm) | -47.27% |
Income Statement
| Revenue (ttm) | 1.32M AUD |
| Revenue Per Share (ttm) | 0.007 AUD |
| Quarterly Revenue Growth (yoy) | 146.19% |
| Gross Profit (ttm) | 718.67K AUD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -4540175 AUD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.81M AUD |
| Total Cash Per Share (mrq) | 0.03 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 19.123 |
| Book Value Per Share (mrq) | 0.036 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4678271 AUD |
| Levered Free Cash Flow (ttm) | -2688321 AUD |
Profile of BCAL Diagnostics Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 50 Clarence Street |
| ZIP | 2000 |
| Phone | 61 2 9078 7671 |
| Website | https://www.bcaldiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Q&A For BCAL Diagnostics Limited Stock
What is a current BDX.AX stock price?
BCAL Diagnostics Limited BDX.AX stock price today per share is 0.11 AUD.
How to purchase BCAL Diagnostics Limited stock?
You can buy BDX.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BCAL Diagnostics Limited?
The stock symbol or ticker of BCAL Diagnostics Limited is BDX.AX.
Which industry does the BCAL Diagnostics Limited company belong to?
The BCAL Diagnostics Limited industry is Diagnostics & Research.
How many shares does BCAL Diagnostics Limited have in circulation?
The max supply of BCAL Diagnostics Limited shares is 252.3M.
What is BCAL Diagnostics Limited Price to Earnings Ratio (PE Ratio)?
BCAL Diagnostics Limited PE Ratio is now.
What was BCAL Diagnostics Limited earnings per share over the trailing 12 months (TTM)?
BCAL Diagnostics Limited EPS is -0.02 AUD over the trailing 12 months.
Which sector does the BCAL Diagnostics Limited company belong to?
The BCAL Diagnostics Limited sector is Healthcare.